安徽建工集团股份有限公司(以下简称"公司")于 2025 年 3 月 6 日召开第九届 董事会第五次会议，并于 2025 年 3 月 27 日召开 2025 年第一次临时股东大会，审议 批准本公司申请发行总额不超过人民币 60 亿元的应收账款资产支持证券。具体内容 详见公司于 2025 年 3 月 7 日披露的《关于 2025 年度债券注册发行计划的公告》（公 告编号：2025-012）。 近日，公司收到中信证券股份有限公司（以下简称"中信证券"）转发的由上海 证券交易所（以下简称"上交所"）出具的《关于对中信证券-安徽建工应收账款 2 号 1-10 期资产支持专项计划资产支持证券挂牌转让无异议的函》（上证函〔2025〕 3785 号）（以下简称"无异议函"），中信证券-安徽建工应收账款 2 号 1-10 期资 产支持专项计划资产支持证券符合上交所的挂牌转让条件，上交所对其挂牌转让无异 议。无异议函主要内容如下： 一、中信证券-安徽建工应收账款 2 号 1-10 期资产支持专项计划资产支持证券采 取分期发行方式，其中，非续发型资产支持证券发行总额不超过 60 亿元，可续发型 资产支持证券各期存量余额合计 0 ...

Core Viewpoint - Anhui Construction (600502.SH) has recently announced that it, along with its subsidiaries, has received bid notifications for two projects, indicating a positive development in its project acquisition strategy [1] Group 1: Project Details - The company has won the bid for the Panji District Environmental Remediation and Ecological Restoration Project with a contract value of 1.214 billion yuan [1] - The company has also secured the bid for the Eastern New City Green Integrated Circuit Industry Park and Infrastructure Construction Project, with a contract value of 1.389 billion yuan [1]

Core Viewpoint - Anhui Construction (600502.SH) has recently announced that it, along with its subsidiaries, has received bid notifications for two projects, indicating a positive development in its project acquisition strategy [1] Group 1: Project Details - The company has won the bid for the Panji District Environmental Improvement and Ecological Restoration Project with a total contract value of 1.214 billion yuan [1] - The company has also secured the bid for the Eastern New Town Green Integrated Circuit Industry Park and Infrastructure Construction Project, with a total contract value of 1.389 billion yuan [1]

人民财讯11月27日电，安徽建工（600502）11月27日公告，近日，本公司及所属子公司收到项目中标通 知书。具体情况公告如下：1.潘集区全区环境整治及生态修复项目EPC总承包中标人为安徽建工集团股 份有限公司(牵头人)、安徽建工淮河建设投资有限公司、安徽建工淮旅建设投资有限公司、淮南新利昂 建设工程有限公司和重庆纵横工程设计有限公司联合体；中标价12.14亿元，其中本公司(含所属子公司) 份额约6亿元。2.东部新城绿色集成电路产业园及基础配套设施建设项目EPC总承包中标人为中铁上海 工程局集团有限公司(牵头人)、中铁上海工程局集团第三工程有限公司、安徽建工(池州)建设投资有限 公司、池州市路桥建设（600263）工程有限公司、池州市规划勘测设计总院（603357）有限公司联合 体；中标价为13.89亿元，其中本公司所属子公司份额约6.95亿元。 ...

Investment Rating - The report maintains an investment rating of "Outperform" for the construction and decoration industry [3]. Core Viewpoints - The report highlights a continued decline in fixed asset investment in October, with a focus on the positive impact of moderately loose monetary policy and the acceleration of strategic project implementation [14][20]. - It emphasizes the increase in net financing of special bonds and rapid deployment of special government bonds, indicating a supportive funding environment for infrastructure projects [21][19]. Summary by Sections Industry Perspective and Investment Recommendations - The construction and decoration index rose by 0.35%, outperforming the overall A-share index by 0.53 percentage points, with notable performances in landscaping engineering and decoration sectors [13][30]. - Fixed asset investment from January to October 2025 reached CNY 408,914 billion, down 1.7% year-on-year, with infrastructure investment at CNY 203,809 billion, growing by 1.5% [14][16]. Key Company Dynamics - China Construction reported a new contract total of CNY 33,194 billion from January to October 2025, up 2.0% year-on-year [37]. - China Metallurgical Group announced a new contract amount of CNY 8,451 billion, down 11.8% year-on-year [37]. Valuation Status - As of November 14, 2025, the price-to-earnings (PE) ratios for various construction sub-sectors were as follows: housing construction at 6.64x, decoration at -24.37x, and municipal engineering at 8.14x [40].

Group 1 - The third extraordinary general meeting of shareholders was held on November 17, 2025, at the company's conference room in Hefei [2][3] - All resolutions presented at the meeting were approved without any objections [2][5] - The meeting was chaired by the company's chairman, Yang Shanbin, and all directors and supervisors were present [3][4] Group 2 - The meeting approved the cancellation of the supervisory board, changes to the business scope, and amendments to the company's articles of association [5][6] - The meeting also approved the revision of the rules for shareholder meetings and board meetings, the appointment of the auditing firm for the 2025 financial report, and an increase in the investment plan for 2025 [6][5] - The meeting was legally valid, as confirmed by the witnessing lawyers from Anhui Tianhe Law Firm [6][8] Group 3 - The company announced that its subsidiary, Anhui Construction Sanjian Group Co., Ltd., received approval to issue debt financing instruments totaling up to RMB 5 billion in short-term financing bonds and RMB 10 billion in medium-term notes [7][8] - The registration for these instruments is valid for two years and will be underwritten by several banks [7][8] - The subsidiary will comply with relevant disclosure obligations as per regulatory requirements [8] Group 4 - The company's 14th board meeting was held on November 17, 2025, with all directors present [11] - The board approved the establishment of Anhui Low Altitude Technology Industry Co., Ltd., with an investment of RMB 70 million from the company [12][13] - The new company will focus on low-altitude industry investments, logistics, infrastructure construction, and technology development [12]

证券日报网讯安徽建工（600502）11月17日在互动平台回答投资者提问时表示，根据公司2025年10月31 日披露的《2025年第三季度报告》，截至2025年9月30日公司股东总数为55，642户。 ...

Group 1 - Yongtai Technology's wholly-owned subsidiary has received approval for trial production of a lithium battery additive project with an annual capacity of 5,000 tons, set to begin trial production [1] - Mengke Pharmaceutical has decided to terminate its plan to issue shares to a specific entity due to ongoing disagreements among major shareholders, which could impact the company's stable operations [1] - Anhui Construction's subsidiary has been approved to register and issue debt financing tools totaling 15 billion yuan, including 5 billion yuan in short-term financing notes and 10 billion yuan in medium-term notes [2] Group 2 - Koli'er plans to repurchase shares worth between 10 million and 20 million yuan, with a maximum repurchase price of 20.94 yuan per share, to implement an employee stock ownership plan [2] - Xinhua Pharmaceutical has received approval for the production of fumaric acid volnoral raw materials, which are used to treat gastroesophageal reflux disease [3] - Lianhuan Pharmaceutical has received approval for additional specifications of tadalafil tablets, expanding its product offerings for treating erectile dysfunction and benign prostatic hyperplasia [5] Group 3 - Greenland Holdings reported an increase of 1,834 lawsuits with a total amount of 6.587 billion yuan from October 21 to November 13, 2025 [7] - Lianke Technology plans to invest up to 600 million yuan of idle funds in low-risk financial products [8] - Yinglian Co. signed a strategic procurement contract for 5,000 million square meters of composite aluminum foil with a leading new energy technology company [10] Group 4 - China Eastern Airlines reported a 10.58% year-on-year increase in passenger turnover for October, with a capacity increase of 6.84% [12] - China National Airlines reported an 8.7% year-on-year increase in passenger turnover for October, with domestic and international capacity also showing growth [15] - Oupai Home plans to use 320 million yuan of idle funds to purchase structured deposits with expected annual yields between 0.65% and 2.50% [16] Group 5 - Tianwei Food has submitted H-share issuance application materials to the Hong Kong Stock Exchange, which have been accepted by the China Securities Regulatory Commission [18] - Guizhou Aviation plans to establish a subsidiary focused on the research, production, and market expansion of intelligent automotive components, with initial operating funds of 40 million yuan [20] - Daimai Co. plans to invest 100 million yuan to establish a wholly-owned subsidiary in Shanghai focused on robotics technology [22] Group 6 - Founder Securities has received approval to issue company bonds totaling up to 30 billion yuan [24] - Hengrui Medicine has received clinical trial approvals for multiple drugs, indicating ongoing research and development efforts [26] - Zhaojing Pharmaceutical's product ZG006 has received orphan drug designation from the FDA, providing various benefits for its development in the U.S. market [39]

证 券 代 码 ： 600502 证 券 简 称 ： 安 徽 建 工 编 号 ： 2025-089 安徽建工集团股份有限公司 关于子公司发行债务融资工具获准注册的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 安徽建工集团股份有限公司(以下简称"公司")于 2025 年 3 月 6 日召开第九届 董事会第五次会议，并于 2025 年 3 月 27 日召开 2025 年第一次临时股东大会，审议 批准控股子公司安徽建工三建集团有限公司（以下简称"建工三建"）申请发行总额 不超过人民币 5 亿元的超短期融资券和总额不超过人民币 10 亿元的中期票据。具体 内容详见公司于 2025 年 3 月 7 日披露的《关于 2025 年度债券注册发行计划的公告》 （公告编号：2025-012）。 近日，建工三建收到中国银行间市场交易商协会（以下简称"中市协"）出具的 《接受注册通知书》（中市协注〔2025〕SCP319 号、中市协注〔2025〕MTN1048 号）， 主要内容如下： 中市协决定接受建工三建超短期融资券和中期票据注册，注册金 ...

证券代码：600502 证券简称：安徽建工 公告编号：2025-088 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 315 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 663,356,569 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 38.6451 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会表决方式符合《公司法》及《公司章程》的规定，会议由公司 董事长杨善斌先生主持。 安徽建工集团股份有限公司 2025年第三次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一) 股东大会召开的时间：2025 年 11 月 17 日 (二)股东大会召开的地点：合肥市黄山路 459 号安建国际大厦公司会议室 (五)公司董事、监事和董事会秘书的出席 ...